treatment of hypertension. profs. abdulqader alhaider; azza el-medany department of pharmacology...

55
TREATMENT OF HYPERTENSION

Upload: nelson-mcbride

Post on 11-Jan-2016

215 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

TREATMENT OF HYPERTENSION

Page 2: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Profs. Abdulqader Alhaider; Azza El-Medany

Department of PharmacologyCollege of Medicine

Page 3: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

OBJECTIVES

• At the end of lectures , the students should :• Identify factors that control blood pressure• Identify the pharmacologic classes of drugs

used in treatment of hypertension• Know examples of each class.

Page 4: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

OBJECTIVES ( continue)

• Describe the mechanism of action , therapeutic uses & common adverse effects of each class of drugs including :

• Adrenoceptor blocking drugs ( β & α blocking drugs )

• Diuretics• Calcium channel blocking drugs• Vasodilators

Page 5: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

OBJECTIVES ( cont.)

• Converting enzyme inhibitors • Angiotensin receptor blockers.• Describe the advantages of ARBs over ACEI

Page 6: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

FACTORS IN BLOOD PRESSURE CONTROL

Page 7: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Hypertension

Blood pressure is determined by :

1- Blood volume

2- Cardiac output ( rate & contractility )

3- Peripheral resistance

Page 8: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

i

Page 9: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Hypertension

• Is a major risk factor for cerebrovascular

disease, heart failure, renal insufficiency

and myocardial infarction.It is often asymptomatic until organ damages

reaches a critical point.

Page 10: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Antihypertensive therapy

• Initially consists of lifestyle changes , such as weight reduction , smoking cessation,

reduction of salt, saturated fat, , excessive alcohol intake , and increased exercise

before drug therapy. Is initiated .

Page 11: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Indications for Drug Therapy Sustained blood pressure elevations > 140/

90 mmHg. when minimally elevated blood pressure is

associated with other cardiovascular risk factors (smoking, diabetes, obesity, hyperlipidemia, genetic predisposition).

When end organs are affected by hypertension (heart, kidney , brain).

Page 12: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Drug Management of Hypertension

Diuretics Cardio inhibitory drugs Beta- blockers Calcium –channel blockers Centrally acting sympatholytic • Vasodilators (a1-antagosits; Hydralazine) • Drugs acting on renin-angiotensin

aldosterone system

Page 13: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine
Page 14: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

B. Potassium-sparing diureticsAmiloride as well as spironolactone reduce potassium loss in the urine. Spironolactone has the additional benefit of diminishing the cardiac remodeling that occurs in heart failure.

Page 15: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Cardio inhibitory Drugs

Page 16: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

β- Adrenoceptor –Blocking Agents

• β- adrenoceptor blocking agents can be used in mild to moderate hypertension.

• In severe cases used in combination with other drugs.

Nadolol (non cardio selective)

Bisoprolol , Atenolol, metoprolol ( cardio selective)

Labetalol , carvidalol ( α – and β adrenergic blockers )

Page 17: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Beta-Adrenoceptor –Blocking Agents

• They lower blood pressure by : Decreasing cardiac output.

Decreasing renin release (very important effect and more related to the clinical response)

Page 18: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

α1-adrenoceptor blockers

• Prazocin , Terazocin

• Added to β- blockers for treatment of hypertension of pheochromocytoma

Page 19: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

CALCIUM CHANNEL BLOCKERSCALCIUM CHANNEL BLOCKERS

Page 20: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

• Classification Dihydropyridine group (Nifedipine,

Nicardipine , Amlodipine (AmlorR) is more selective as vasodilator than a cardiac depressant. This group is used for treatment of hypertension

Verapamil is more effective as cardiac depressant , therefore it is not used

as antihypertensive agent . Diltiazem .Used mainly for angina

Page 21: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

❏ Mechanism of Action: (Arterial) Block the influx of calcium through L-type calcium channels resulting in: 1- Peripheral vasodilatation (at arteries) 2- Decrease cardiac contractility & heart rate??

Both effects lower blood pressure

Page 22: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Pharmacokinetics:❏ given orally and intravenous injection

❏ well absorbed from G.I.T

❏ verapamil and nifedipine are highly bound to plasma protiens ( more than 90%) while diltiazem is less ( 70-80%)

Page 23: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

(Cont’d):

❏ onset of action --- within 1-3 min --- after i.v. 30 min – 2 h --- after oral dose

❏ verapamil & diltiazem have active metabolites, nifedipine does not

❏ sustained-release preparations can permit once-daily dosing

Page 24: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Clinical uses

• Treatment of chronic hypertension with oral preparation

• Nifedipine used for Raynoids phenomena

• Nicardipine can be given by I.V. route & used in hypertensive emergency

Page 25: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

ADVERSE EFFECTSVerapamil Diltiazem Nifedipine

Headache , Flushing , Hypotension

Headache, Flushing, Hypotension

Headache , Flushing, Hypotension

Peripheral edema (ankle edema)

Peripheral edema (ankle edema)

Peripheral edema (ankle edema)

Cardiac depression, A-V block , bradycardia

Cardiac depression , A-V block , bradycardia

Reflex Tachycardia

Constipation

Page 26: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Centrally acting sympatholytic drugs e.g. Clonidine direct

α2-agonist Reduce sympathetic outflow

to the heart thereby decreasing cardiac output (by decreasing heart rate & contractility ).

Reduced sympathetic output to the vasculature, decreases sympathetic vascular tone , which causes vasodilation & reduced systemic vascular resistance, which decreases arterial pressure.

Page 27: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

α methyl dopaindirect

• α 2 agonist is converted to methyl norepinephrine centrally to diminish the adrenergic outflow from the C.N.S. This lead to reduced total peripheral resistance, and a decreased blood pressure.

• Safely used in hypertensive pregnant women

Page 28: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Side effects of centrally acting sympatholyics

• Depression• Dry mouth, nasal mucosa• Bradycardia• Impotence• Postural hypotension• Fluid retention & edema with chronic use• Sudden withdrawal of clonidine can lead to

rebound hypertension

Page 29: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

VASODILATORSVASODILATORS

Page 30: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Compensatory Response to Vasodilators

Page 31: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

VasodilatorsHydralazi

neMinoxidil Diazoxid

eNa

nitropruside

Site of action

Arteriodilator Arteriodilator Arteriodilator Arterio & venodilator

Mechanism of action

Direct Opening of potassium channels in smooth muscle membranes by minoxidil sulfate ( active metabolite )

Opening of potassium channels

Release of nitric oxide ( NO)

Route of admin.

Oral Oral Rapid intravenous

Intravenous infusion

Page 32: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

ContinueVasodilators

Hydralazine Minoxidil Diazoxide Na nitropruside

Therapeutic uses

1.Moderate -severe hypertension.CHF

1.severe hypertension

1.Hypertensive emergency( in the past )

1.Hpertensive emergency

2.Hypertensive pregnant woman

2.correction of baldness

2.Treatment of hypoglycemia due to insulinoma

Page 33: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

ContinueVasodilators

Hydralazine Minoxidil Diazoxide Na nitropruside

Adverse effects

Hypotension, reflex tachycardia, palpitation, angina, salt and water retention ( edema)

Severe hypotension

Specific adverse effects

lupus erythematosus like syndrome

Hypertrichosis.

Contraindicated in females

Inhibit insulin release from β cells of the pancreas causing hyperglycemia

Contraindicated in diabetic

1.Methemoglobinduring infusion2. Cyanide toxicity3. Thiocyanate toxicity

Page 34: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Give reason : β-blockers & diuretics are added to

vasodilators for treatment of hypertension?

Page 35: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

te

Page 36: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Endothelium, brain &

Other Proteolytic Enzymes Chymase

Endoperoxidase

A vasoconstrictor peptide

Synthesis

Precursor is Angiotensinogen; a plasma -globulin synthesized in the liver.

Secreted by renal juxtaglomerular apparatus

AT1

AT2

Renal SN activation Renal SN activation Renal Blood flow by2 agonists & PGI2Renal Blood flow by2 agonists & PGI2Blood Pressure

Page 37: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

angiotensin-converting

enzyme

Angiotensin I(inactive)

Angiotensin II(active vasoconstrictor)

Bradykinin(active vasodilator)

Inactive metabolites

ACE inhibitors

Mechanism of action of Angiotensin-converting enzyme inhibitors (ACEI)

angiotensin-converting

enzyme

Angiotensin I(inactive)

Angiotensin II(active vasoconstrictor)

Bradykinin(active vasodilator)

Inactive metabolites

Page 38: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Mechanism of action:

Converting enzyme inhibitors lower blood pressure by reducing angiotensin II, and also by increasing

vasodilator peptides such as bradykinin.

reduction of sympathetic activity (use is not associated with reflex tachycardia despite causing arterioral and venous dilatation)

Reduce the arteriolar and left ventricular remodelling that are believed to be important in the pathogenesis of human

essential hypertension and post-infarction state

Dilatation of arteriol reduction of peripheral vascular resistance (afterload )

Increase of Na+ and decrease of K+ excretion in kidney by inhibition Aldosterone secretion

Page 39: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Pharmacokinetics

• Captopril, Lisonopril; Enalapril and Ramipril .• All are rapidly absorbed from GIT after oral

administration.• Food reduce their bioavailability.• Enalapril , ramipril are prodrugs, converted to the

active metabolite in the liver • Have a long half-life & given once daily except

Captopril• Enalaprilat is the active metabolite of enalapril

given by i.v. route in hypertensive emergency.

Page 40: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Phrmacokinetics

• Captopril is not a prodrug • Has a short half-life & given twice /day

• All ACEI are distributed to all tissues except CNS.

Page 41: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Clinical uses Treatment of hypertension

Treatment of heart failure

Diabetic nephropathy . How do they work?

Page 42: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

ADVERSE EFFECTS:

Acute renal failure, especially in patients

with bilateral renal artery stenosis

Hyperkalemia How?

Page 43: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

(Cont’d):

Persistent cough

Angioneurotic edema (swelling in the nose , throat,tongue, larynx)

Page 44: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

(Cont’d):

( cough & edema due to bradykinin)

severe hypotension in hypovolemic patients (due to diuretics, salt restriction or gastrointestinal fluid loss)

Page 45: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

(Cont’d):

Taste loss

Skin rash, fever

( taste loss. is due to a sulfhydryl group in the molecule of captopril ).

Page 46: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Contraindications

• During the second and third trimesters of pregnancy due to the risk of : fetal hypotension, anuria, renal failure &

malformations .• Bilateral renal artery stenosis or stenosis of a

renal artery with solitary kidney. How?

Page 47: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Drug interactions

• With potassium-sparing diuretics (e.g: Spirinolactone)

• NSAIDs impair their hypotensive effects by blocking bradykinin-mediated

vasodilatation.

Page 48: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

BLOCKERS OF AT1 RECEPTORlosartan, valosartan, irbesartan

- competitively inhibit angiotensin II at its AT1 receptor site

most of the effects of angiotensin II - including vasoconstriction and aldosterone release - are mediated by the AT1 receptorthey influence RAS more effective because of selective blockade (angiotensin II synthesis in tissue is not completely dependent only on renin release, but could be promote by serin- protease -

Page 49: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

angiotensinogen

angiotensin I

angiotensin II

renin

ACE

nonrenin proteasescathepsin

t-PAchymaseCAGE

Page 50: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Continue

They have no effect on bradykinin system

causing neither: cough, wheezing nor

angioedema

Page 51: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Losartan, valsartan , irbesartan

Page 52: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Adverse effects• As ACEI except cough,wheezing, and

angioedema.

• Same contraindications as ACEI.

Page 53: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Drug Combination for Hypertension

• Hydrochlorothiazide (12.5 mg+ Valsartan • (60 or 80 mg) (Co-DiovanR)• Hydrochlorothiazide (12.5 mg + Losartan (50 or 100 mg)• Hydrochlorothiazide (12.5 mg + Lisinopril

(10 or 20 mg)

Page 54: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

Drugs for treatment of hypertensive crisis

• Labetalol• Hydralazine (in pregnancy)

• Sodium nitroprusside (2nd line)General characters of good drug for Crisis:• Fast & short acting• Given by IV

Page 55: TREATMENT OF HYPERTENSION. Profs. Abdulqader Alhaider; Azza El-Medany Department of Pharmacology College of Medicine

THANK YOU